Nomura Securities Downgrades Synageva BioPharma (GEVA) to Neutral Amid Takeover May 7, 2015 08:54AM
Nomura Downgrades Pharmacyclics (PCYC) to Neutral; Deal Supports Further M&A (INFI) (RCPT) (ICPT) (INCY) (NBIX) (GEVA) Mar 5, 2015 01:15PM
Synageva BioPharma (GEVA) Prices Larger 3M Common Offering at $94.19/Share Jan 7, 2015 07:40AM
Synageva (GEVA) PT Raised to $124 at Nomura Jan 5, 2015 11:09AM
Synageva BioPharma (GEVA) PT Cut, 'Buy' Maintained at Nomura Securities Sep 29, 2014 10:11AM


May 1, 2014 07:38AM Synageva BioPharma (GEVA) PT Trimmed Post 'Non-Event' Q1 Earnings
Mar 5, 2014 05:40PM Synageva BioPharma (GEVA) Prices 2M Share Offering at $105.75
Mar 4, 2014 08:28AM Synageva BioPharma (GEVA) Target Lifted to $144 at Nomura
Jan 16, 2014 07:53AM Synageva BioPharma (GEVA) Target Raised Sharply at Nomura on Confidence in Sebelipase Launch
Jan 8, 2014 07:55AM Nomura Securities Starts Synageva BioPharma (GEVA) at Buy, $85 PT